333 related articles for article (PubMed ID: 27638202)
21. TIME for Bugs: The Immune Microenvironment and Microbes in Precancer.
Borthwick Bowen M; Helmink BA; Wargo JA; Yates MS
Cancer Prev Res (Phila); 2023 Sep; 16(9):497-505. PubMed ID: 37428011
[TBL] [Abstract][Full Text] [Related]
22. The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities.
Srivastava S; Ghosh S; Kagan J; Mazurchuk R;
Trends Cancer; 2018 Aug; 4(8):523-536. PubMed ID: 30064661
[TBL] [Abstract][Full Text] [Related]
23. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
Young MR; Levingston CA; Johnson SD
Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
[TBL] [Abstract][Full Text] [Related]
24. Fourier transform infrared microspectroscopy as a quantitative diagnostic tool for assignment of premalignancy grading in cervical neoplasia.
Mark S; Sahu RK; Kantarovich K; Podshyvalov A; Guterman H; Goldstein J; Jagannathan R; Argov S; Mordechai S
J Biomed Opt; 2004; 9(3):558-67. PubMed ID: 15189094
[TBL] [Abstract][Full Text] [Related]
25. Unprecedented opportunities and promise for cancer prevention research.
Blackburn EH; Tlsty TD; Lippman SM
Cancer Prev Res (Phila); 2010 Apr; 3(4):394-402. PubMed ID: 20354163
[TBL] [Abstract][Full Text] [Related]
26. Laryngeal dysplasia: aetiology and molecular biology.
Sadri M; McMahon J; Parker A
J Laryngol Otol; 2006 Mar; 120(3):170-7. PubMed ID: 16372991
[TBL] [Abstract][Full Text] [Related]
27. Penile intraepithelial neoplasia: Nomenclature, incidence and progression to malignancy in the Netherlands.
Hoekstra RJ; Trip EJ; Ten Kate FJ; Horenblas S; Lock MT
Int J Urol; 2019 Mar; 26(3):353-357. PubMed ID: 30508877
[TBL] [Abstract][Full Text] [Related]
28. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
29. Cancer immunoprevention: a new approach to intercept cancer early.
Umar A
Cancer Prev Res (Phila); 2014 Nov; 7(11):1067-71. PubMed ID: 25237055
[TBL] [Abstract][Full Text] [Related]
30. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
31. Cancer prevention: from 1727 to milestones of the past 100 years.
Lippman SM; Hawk ET
Cancer Res; 2009 Jul; 69(13):5269-84. PubMed ID: 19491253
[TBL] [Abstract][Full Text] [Related]
32. Penile intraepithelial neoplasia and other premalignant lesions of the penis.
Crispen PL; Mydlo JH
Urol Clin North Am; 2010 Aug; 37(3):335-42. PubMed ID: 20674690
[TBL] [Abstract][Full Text] [Related]
33. The Conundrum of Genetic "Drivers" in Benign Conditions.
Kato S; Lippman SM; Flaherty KT; Kurzrock R
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27059373
[TBL] [Abstract][Full Text] [Related]
34. Histological and biological evolution of human premalignant breast disease.
Allred DC; Mohsin SK; Fuqua SA
Endocr Relat Cancer; 2001 Mar; 8(1):47-61. PubMed ID: 11350726
[TBL] [Abstract][Full Text] [Related]
35. Immune response to premalignancy: insights from patients with monoclonal gammopathy.
Dhodapkar MV
Ann N Y Acad Sci; 2005 Dec; 1062():22-8. PubMed ID: 16461785
[TBL] [Abstract][Full Text] [Related]
36. Underwriting implications of premalignant disease.
Vecchione L
J Insur Med; 1998; 30(3):169-74. PubMed ID: 10351177
[TBL] [Abstract][Full Text] [Related]
37. Mast cells in colorectal neoplasias and premalignant disorders.
Lachter J; Stein M; Lichtig C; Eidelman S; Munichor M
Dis Colon Rectum; 1995 Mar; 38(3):290-3. PubMed ID: 7882795
[TBL] [Abstract][Full Text] [Related]
38. Clonal evolution models of tumor heterogeneity.
Shlush LI; Hershkovitz D
Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
[TBL] [Abstract][Full Text] [Related]
39. Senescence and pre-malignancy: how do tumors progress?
Saab R
Semin Cancer Biol; 2011 Dec; 21(6):385-91. PubMed ID: 21982725
[TBL] [Abstract][Full Text] [Related]
40. Premalignant Clonal Hematopoietic Proliferations.
Nardi V; Kuo FC; Hasserjian RP
Am J Clin Pathol; 2019 Aug; 152(3):347-358. PubMed ID: 31305863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
